Drug-induced shortening of the electromechanical window is an effective biomarker for in silico prediction of clinical risk of arrhythmias.
Elisa PassiniCristian TrovatoPierre MorissetteFrederick SannajustAlfonso Bueno-OrovioBlanca RodriguezPublished in: British journal of pharmacology (2019)
The EMw is an effective biomarker for in silico predictions of drug-induced clinical pro-arrhythmic risk, particularly for compounds with multichannel blocking action.